Search PubMed⌕ Search

Biomedical subjects

J Viikari

Publications and source records attributed to J Viikari.

At least 217 records · Page 12Linked to original sources

Determinants of total and high density lipoprotein cholesterol in boys from Finland, The Netherlands, Italy, the Philippines and Ghana with special reference to diet.

We have studied the determinants of total and high density lipoprotein (HDL) cholesterol in young boys from five countries characterized by different lifestyles, dietary consumption profiles and mortality rates from coronary heart disease. All measurements including the estimation of dietary intake, physical activity, body mass index and the concentrations of total and HDL cholesterol were carefully standardized. The mean concentrations of total and HDL cholesterol were higher in the European boys (4.1-4.9 mmol/l and 1.45-1.57 mmol/l, respectively) than in the boys from Ghana and the Philippines (3.3-3.8 mmol/l and 0.93-1.10 mmol/l, respectively). A positive correlation was found between the concentration of total cholesterol and the intake of saturated fatty acids in four out of five countries. The concentration of HDL cholesterol was also related to various dietary variables in some of the groups. Using the regression coefficients from a multiple regression analysis on the pooled data, it could be calculated that on average 24 per cent of the inter-country differences in the levels of total cholesterol is explained by differences in the intakes of saturated fatty acids. Differences between the groups of the different countries in the intakes of carbohydrate explained on average 29 per cent of the differences in the concentrations of HDL cholesterol. The results obtained support the hypothesis that higher concentrations of total and HDL cholesterol are associated with western types of diets rich in saturated fatty acids and relatively poor in complex carbohydrates.

Anthropometry↗

The use of clofibrate in patients with renal insufficiency.

Serum clofibrinic acid (CPIB) levels after single and multiple oral doses of clofibrate were studied in 28 patients with elevated serum creatinine values. The half-life of CPIB was prolonged in proportion to the serum creatinine level (r = 0.818 p less than 0.001). Peak CPIB concentrations in serum were not affected by azotemia, although CPIB levels 24 h after a single dose and under steady-state conditions correlated well with the serum creatinine level. The proportion of unbound CPIB was higher in patients with renal insufficiency than in controls (13.9% vs 4.3%), although this difference did not correlate with the serum creatinine level. Hypolipidemic medication is indicated in dyslipoproteinemias associated with renal insufficiency. If a reduced dose is given, clofibrate can be used safely in renal patients, although a CPIB concentration of 70 mg/l in serum should not be exceeded unless the unbound fraction has been measured and found not to exceed a safe level (i.e., 6 mg/l CPIB).

Adolescent↗

Effect of pindolol on serum lipoproteins in patients with coronary heart disease.

The effect of pindolol, a beta blocker with intrinsic sympathomimetic activity (ISA), on serum lipoprotein composition was studied in 13 patients admitted to the hospital for an attack of coronary heart disease. The control group consisted of 11 coronary patients without any beta-blocker therapy. Pindolol therapy was started during the stay in the hospital with a dose of 2.5-5.0 mg 2-3 times daily (mean dose 7.5 mg daily) and continued unaltered throughout the study. Serum samples were taken upon admission to the hospital and 4-6 months later, when the effect of acute coronary heart attack was stabilized. Initial serum cholesterol and HDL-cholesterol values were 6.82 mmol/l and 1.04 mmol/l, respectively. The ratio of HDL-cholesterol to total cholesterol (HDL/total) was 0.155 and serum triglycerides 1.78 mmol/l. During the pindolol therapy HDL-cholesterol and the HDL/total ratio increased by 12.5 and 11.2%, respectively, and the triglyceride level decreased by 16.9%. These changes, however, were not statistically significant due to interindividual variation. The results suggest that pindolol, unlike some other beta blockers, has no harmful effect on lipoprotein metabolism. This finding may have relevance when choosing a beta blocker for a patient with coronary heart disease.

Cholesterol↗

Effect of beta 2-adrenergic stimulation on serum lipids.

The effect of a beta 2-adrenoceptor agonist, salbutamol, on serum lipids was studied over a 3-month period. Thirteen patients with bronchial asthma were treated with 2 mg salbutamol three times daily (one patient with 4 mg three times daily). The concentrations of serum total cholesterol and LDL-cholesterol were slightly but not statistically significantly higher after 3 months with salbutamol than before the medication. The serum HDL-cholesterol and triglyceride concentrations remained constant during the therapy. Serum free fatty acid levels decreased slightly but not significantly during the therapy. Treatment with salbutamol did not elevate plasma free fatty acid levels, which may have arrhythmic effects. The results indicate that beta 2-adrenergic stimulation has no effect on basal serum lipid levels.

Adrenergic beta-Agonists↗

Multicenter study of atherosclerosis precursors in Finnish children--pilot study of 8-year-old boys.

A multicentre study was launched to analyze the prevalence of risk factors for coronary heart disease and their determinants in Finnish infants, children and adolescents and to provide facts for the planning of intervention. The present report gives the results of the pilot study conducted among 264 8-year-old boys in 5 cities and corresponding rural areas in various parts of Finland. Data on eating habits were obtained from the parents by means of a questionnaire. Fasting serum specimens were analyzed in 249 subjects for cholesterol, HDL-cholesterol, triglycerides, and immunoreactive insulin (IRI). The fatty acid composition of serum lipids was determined in 244 subjects by gas chromatography. Soft vegetable margarine was used on bread by 29% of the boys in the rural and 46% in the urban areas. Low fat or skim milk, vegetables and fruit were used more often in the western than in the eastern part of the country. The mean values for serum lipids were as follows: cholesterol 5.0, HDL-cholesterol 1.4, and triglycerides 0.7 mmol/1. The proportion of linoleic acid in the fatty acid cholesterol ester fraction was higher than expected, 53%. The IRI values ranged from 2 to 55 (mean, antilog, 9.4) mU/l. The results served as background material for the main study of blood pressure, anthropometric, biochemical and socioeconomic variables.

Arteriosclerosis↗

Effect of procetofen on apolipoprotein A I and B concentrations in hyperlipoproteinemia.

Thirty-three hyperlipoproteinemic patients were subjected to therapy with procetofen (300-600 mg daily) for 6 months in a placebo-controlled study. Lipoprotein changes based on cholesterol fractions have been reported previously. This report shows that procetofen increase Apo A I only slightly. Apoprotein B decreased by 16% and the ratio of Apo A I to Apo B was increased by 31%. In addition, procetofen induces changes in HDL composition: the relative amount of cholesterol is increased, which may reflect more efficient efflux of cholesterol from the tissues.

Adult↗

Chlorpropamide and glibenclamide serum concentrations in hospitalized patients.

The relationships between the daily doses of the drugs and the steady state serum concentration was studied in 51 patients on chlorpropamide and in 27 patients on glibenclamide. All the patients were hospitalized during the study. A wide interindividual variation in chlorpropamide levels was observed and thus, the prediction of drug concentration was difficult from the dosage alone, despite a statistically significant correlation between the dose per body weight and the serum drug level. The differences could not be explained on the serum creatinine levels, age, sex, liver diseases or other drugs used concomitantly. In the case of glibenclamide, a wide interindividual variation in serum concentration of the drug also occurred.

Aged↗

Fenofibrate and cholestyramine in type II hyperlipoproteinaemia.

The effect of fenofibrate (300-600 mg daily) was compared with cholestyramine (12 g daily) in 13 patients with primary type II hyperlipoproteinaemia. Seven of the patients had monogenic familial hypercholesterolaemia. Both fenofibrate (21.0%) and cholestyramine (18.5%) decreased serum cholesterol level. Fenofibrate (22.7%) and cholestyramine (19.6%) had equally decreasing effects on LDL-cholesterol, but fenofibrate increased HDL-cholesterol (10.4%), although not significantly, whereas cholestyramine decreased the HDL-cholesterol (11.9%). Therefore the ratio of HDL-cholesterol to total cholesterol was higher after fenofibrate (0.17) than after cholestyramine (0.13). Serum triglyceride concentration decreased by 57.1 per cent during six months' treatment with fenofibrate, but returned to a higher level during 3 months' cholestyramine treatment. When the dose of fenofibrate was increased from 300 mg to 600 mg daily, serum cholesterol, LDL-cholesterol, and triglyceride values decreased, and HDL-cholesterol and the ratio of HDL-cholesterol to total cholesterol increased, but only in patients with non-familial hypercholesterolaemia. Fenofibrate is in addition to cholestyramine an useful hypolipidaemic drug in type II hyperlipoproteinaemia.

Adult↗

Type IIA hyperlipoproteinemic sera decrease the synthesis of hyaluronic acid by cultured human aortic smooth muscle cells.

The synthesis of sulphated glucosaminoglycans (S-GAGs) and hyaluronic acid (HA) by cultured human aortic smooth muscle cells (SMC) was measured in the presence of sera from type IIA hyperlipoproteinemic patients (7 males and 6 females) and their age- and sex-matched controls. Experiments with pooled sera showed that type IIA and control sera differed in their effects on the synthesis of GAGs at high serum concentrations with preincubation times of 24 and 48 h. Therefore, individual sera were tested at 15% with 24 h preincubation. Type IIA sera decreased the synthesis of HA by 21% (P less than 0.001) but had no significant effect on sulphated GAGs. The ratio of sulphated GAGs to Ha was higher in the presence of type IIA sera than control sera. The incorporation of thymidine, the number of cells and the amount of DNA did not differ in cultures incubated with type IIA and control sera. Early human and experimental atherosclerotic lesions are known to have an increased sulphated GAGs to HA ratio. Our results suggest that one explantation for the association between type IIA hyperlipoproteinemia and an increased risk for atherosclerosis is the disturbance in the proportions of hyaluronic acid and sulphated GAGs synthesized by arterial SMC.

Adult↗

Achilles tendon thickness in hypercholesterolaemia.

The maximum thickness of the achilles tendon was measured by radiographic technique in twenty-six hypercholesterolaemic patients and thirty-four controls. There were thirteen patients with diagnostic criteria of familial hypercholesterolaemia. All achilles tendons except one of the familial hypercholesterolaemic patients were thicker than normal, but in the non familial hypercholesterolaemic group the thickness of achilles tendons was within normal limits. Achilles tendon thickness and age were positively correlated in II A familial type patients, but not in controls or in the non-familial group. A strongly positive correlation between Achilles tendon thickness and the age multiplied by the serum cholesterol level was seen in familial type II A patients. The Achilles tendon thickness and serum HDL-cholesterol concentration were not correlated. The radiographic measurement of Achilles tendon thickness seems to be a useful procedure for detecting familial hypercholesterolaemia.

Achilles Tendon↗

Cigarette smoke affects lipolytic activity in isolated rat lungs.

Isolated perfused rat lungs liberated fatty acids at a rate of 15 mumol/hr during perfusion of triglyceride-rich medium through the pulmonary vascular bed. About 80% of this activity seemed to result from lipoprotein lipase and 20% to hormone-sensitive lipase. Ventilation of the lungs with cigarette smoke instead of air during the perfusion reduced fatty acid liberation by 23%. Pre-exposure of rats to cigarette smoke for either 1 or 10 days did not cause significant changes in lung lipolytic activity compared to sham-exposed controls.

Animals↗